| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | SVP, Finance &CAO | SVP, Finance &CAO +1 more
1 company
Utter Christine Marie is a SVP, Chief Accounting Officer at PTCT. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $5.3M at current prices.
Our model assigns Utter Christine Marie a middling insider score of 58/100, based on 22 past trades. Over a 12-month horizon, 36.8% of those trades were profitable, with an average 12-month return of -11.8%.
Utter Christine Marie's largest disclosed position is in PTCT as SVP, Chief Accounting Officer, worth about $5.3M. The recent filings there lean toward selling, a net 212,611 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 4,688 | $47.79 | $224,044.17 | -11.0% | -14.7% | -39.6% | |
| Mar 27, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 26,658 | $45.09 | $1,202,105.75 | -41.2% | -11.7% | -38.9% | |
| Jan 31, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 325 | $45.63 | $14,829.10 | -0.8% | +20.2% | -43.1% | |
| Jan 11, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 906 | $43.59 | $39,492.14 | -2.3% | +6.1% | -37.1% | |
| Jan 9, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 706 | $41.66 | $29,409.28 | -1.8% | +16.9% | -31.0% | |
| Feb 2, 2022 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 1,020 | $40.26 | $41,069.29 | -3.9% | -9.2% | +20.2% | |
| Jan 18, 2022 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 11,428 | $43.94 | $502,118.00 | -30.2% | +3.3% | +13.9% | |
| Jan 7, 2022 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 747 | $38.53 | $28,778.18 | -4.4% | +12.9% | +3.2% | |
| Feb 8, 2021 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 2,657 | $66.00 | $175,362.00 | -13.9% | - | - | |
| Feb 2, 2021 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 1,020 | $57.39 | $58,541.09 | -5.8% | - | - |